Skip to main content
Top
Published in: Diabetologia 9/2010

Open Access 01-09-2010 | Article

Capillary pressure may predict preclinical changes in the eye

Authors: K. M. Gooding, J. E. Tooke, H. von Lany, M. Mitra, R. Ling, C. I. Ball, D. Mawson, K. Skinner, A. C. Shore

Published in: Diabetologia | Issue 9/2010

Login to get access

Abstract

Aims/hypothesis

Microvascular dysfunction is associated with end-organ damage. Macular oedema is an important component of diabetic retinopathy. Macular thickness can be accurately quantified by optical coherence tomography (OCT), enabling accurate assessment of the macular prior to clinically apparent abnormalities. We investigated whether macular (fovea) thickness in non-diabetic individuals is related to the microvascular variables controlling fluid filtration across a blood vessel wall, in particular capillary pressure and the microvascular filtration capacity (Kf).

Methods

We recruited 50 non-diabetic individuals (25 men, 25 women; age range: 26–78 years; BMI range: 20–46 kg/m2). Fovea thickness was assessed by OCT. Microvascular assessments included: finger nailfold capillary pressure; Kf; microvascular structural assessments, i.e. skin vasodilatory capacity, minimum vascular resistance (MVR) and microvascular distensibility; and endothelial function.

Results

At 214.6 (19.9) µm (mean [SD]), fovea thickness was within normal range. Capillary pressure, adjusted for BMI, was associated with fovea thickness (standardised beta 0.573, p = 0.006, linear regression). Fovea thickness was not associated with Kf, microvascular structural assessments or endothelial function. Capillary pressure was still associated with fovea thickness when adjusted for microvascular variables (Kf, vasodilatory capacity, MVR, microvascular distensibility or endothelial function), or for risk factors for diabetes (systemic blood pressure, insulin sensitivity, inflammation, glycaemic status and lipids) and age.

Conclusions/interpretation

Capillary pressure, a key determinant of movement of fluid across a blood vessel wall, is associated with fovea thickness in non-diabetic individuals. This suggests that with regard to potential preventative or therapeutic targets, attention should be directed at the mechanisms determining retinal microvascular pressure.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ikram MK, Janssen JA, Roos AM et al (2006) Retinal vessel diameters and risk of impaired fasting glucose or diabetes: the Rotterdam study. Diabetes 55:506–510CrossRefPubMed Ikram MK, Janssen JA, Roos AM et al (2006) Retinal vessel diameters and risk of impaired fasting glucose or diabetes: the Rotterdam study. Diabetes 55:506–510CrossRefPubMed
2.
go back to reference Klein R, Klein BE, Moss SE, Wong TY (2006) The relationship of retinopathy in persons without diabetes to the 15-year incidence of diabetes and hypertension: Beaver Dam Eye Study. Trans Am Ophthalmol Soc 104:98–107PubMed Klein R, Klein BE, Moss SE, Wong TY (2006) The relationship of retinopathy in persons without diabetes to the 15-year incidence of diabetes and hypertension: Beaver Dam Eye Study. Trans Am Ophthalmol Soc 104:98–107PubMed
3.
go back to reference Nguyen TT, Wang JJ, Islam FM et al (2008) Retinal arteriolar narrowing predicts incidence of diabetes: the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study. Diabetes 57:536–539CrossRefPubMed Nguyen TT, Wang JJ, Islam FM et al (2008) Retinal arteriolar narrowing predicts incidence of diabetes: the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study. Diabetes 57:536–539CrossRefPubMed
4.
go back to reference Wong TY, Shankar A, Klein R, Klein BE, Hubbard LD (2005) Retinal arteriolar narrowing, hypertension, and subsequent risk of diabetes mellitus. Arch Intern Med 165:1060–1065CrossRefPubMed Wong TY, Shankar A, Klein R, Klein BE, Hubbard LD (2005) Retinal arteriolar narrowing, hypertension, and subsequent risk of diabetes mellitus. Arch Intern Med 165:1060–1065CrossRefPubMed
5.
go back to reference Wong TY, Klein R, Sharrett AR et al (2002) Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. JAMA 287:2528–2533CrossRefPubMed Wong TY, Klein R, Sharrett AR et al (2002) Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. JAMA 287:2528–2533CrossRefPubMed
6.
go back to reference Kifley A, Wang JJ, Cugati S, Wong TY, Mitchell P (2008) Retinal vascular caliber and the long-term risk of diabetes and impaired fasting glucose: the Blue Mountains Eye Study. Microcirculation 15:373–377CrossRefPubMed Kifley A, Wang JJ, Cugati S, Wong TY, Mitchell P (2008) Retinal vascular caliber and the long-term risk of diabetes and impaired fasting glucose: the Blue Mountains Eye Study. Microcirculation 15:373–377CrossRefPubMed
7.
go back to reference Mitchell P, Wang JJ, Wong TY, Smith W, Klein R, Leeder SR (2005) Retinal microvascular signs and risk of stroke and stroke mortality. Neurology 65:1005–1009CrossRefPubMed Mitchell P, Wang JJ, Wong TY, Smith W, Klein R, Leeder SR (2005) Retinal microvascular signs and risk of stroke and stroke mortality. Neurology 65:1005–1009CrossRefPubMed
8.
go back to reference Wang JJ, Liew G, Klein R et al (2007) Retinal vessel diameter and cardiovascular mortality: pooled data analysis from two older populations. Eur Heart J 28:1984–1992CrossRefPubMed Wang JJ, Liew G, Klein R et al (2007) Retinal vessel diameter and cardiovascular mortality: pooled data analysis from two older populations. Eur Heart J 28:1984–1992CrossRefPubMed
9.
go back to reference Witt N, Wong TY, Hughes AD et al (2006) Abnormalities of retinal microvascular structure and risk of mortality from ischemic heart disease and stroke. Hypertension 47:975–981CrossRefPubMed Witt N, Wong TY, Hughes AD et al (2006) Abnormalities of retinal microvascular structure and risk of mortality from ischemic heart disease and stroke. Hypertension 47:975–981CrossRefPubMed
10.
go back to reference Wong TY, Klein R, Couper DJ et al (2001) Retinal microvascular abnormalities and incident stroke: the atherosclerosis risk in communities study. Lancet 358:1134–1140CrossRefPubMed Wong TY, Klein R, Couper DJ et al (2001) Retinal microvascular abnormalities and incident stroke: the atherosclerosis risk in communities study. Lancet 358:1134–1140CrossRefPubMed
11.
go back to reference Wong TY, Klein R, Sharrett AR et al (2003) The prevalence and risk factors of retinal microvascular abnormalities in older persons: The Cardiovascular Health Study. Ophthalmology 110:658–666CrossRefPubMed Wong TY, Klein R, Sharrett AR et al (2003) The prevalence and risk factors of retinal microvascular abnormalities in older persons: The Cardiovascular Health Study. Ophthalmology 110:658–666CrossRefPubMed
12.
go back to reference Cooper LS, Wong TY, Klein R et al (2006) Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. Stroke 37:82–86CrossRefPubMed Cooper LS, Wong TY, Klein R et al (2006) Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. Stroke 37:82–86CrossRefPubMed
13.
go back to reference Tikellis G, Arnett DK, Skelton TN et al (2008) Retinal arteriolar narrowing and left ventricular hypertrophy in African Americans. The Atherosclerosis Risk in Communities (ARIC) study. Am J Hypertens 21:352–359CrossRefPubMed Tikellis G, Arnett DK, Skelton TN et al (2008) Retinal arteriolar narrowing and left ventricular hypertrophy in African Americans. The Atherosclerosis Risk in Communities (ARIC) study. Am J Hypertens 21:352–359CrossRefPubMed
14.
go back to reference Wong TY, Klein R, Nieto FJ et al (2003) Retinal microvascular abnormalities and 10-year cardiovascular mortality: a population-based case–control study. Ophthalmology 110:933–940CrossRefPubMed Wong TY, Klein R, Nieto FJ et al (2003) Retinal microvascular abnormalities and 10-year cardiovascular mortality: a population-based case–control study. Ophthalmology 110:933–940CrossRefPubMed
15.
go back to reference Chan NN, Colhoun HM, Vallance P (2001) Cardiovascular risk factors as determinants of endothelium-dependent and endothelium-independent vascular reactivity in the general population. J Am Coll Cardiol 38:1814–1820CrossRefPubMed Chan NN, Colhoun HM, Vallance P (2001) Cardiovascular risk factors as determinants of endothelium-dependent and endothelium-independent vascular reactivity in the general population. J Am Coll Cardiol 38:1814–1820CrossRefPubMed
16.
go back to reference Ijzerman RG, de Jongh RT, Beijk MAM et al (2003) Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skin. Eur J Clin Investig 33:536–542CrossRef Ijzerman RG, de Jongh RT, Beijk MAM et al (2003) Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skin. Eur J Clin Investig 33:536–542CrossRef
17.
go back to reference Strain WD, Chaturvedi N, Leggetter S et al (2005) Ethnic differences in skin microvascular function and their relation to cardiac target-organ damage. J Hypertens 23:133–140CrossRefPubMed Strain WD, Chaturvedi N, Leggetter S et al (2005) Ethnic differences in skin microvascular function and their relation to cardiac target-organ damage. J Hypertens 23:133–140CrossRefPubMed
18.
go back to reference Strain WD, Chaturvedi N, Bulpitt CJ, Rakijumar C, Shore AC (2005) Albumin excretion rate and cardiovascular risk: could the association be explained by early microvascular dysfunction? Diabetes 54:1816–1822CrossRefPubMed Strain WD, Chaturvedi N, Bulpitt CJ, Rakijumar C, Shore AC (2005) Albumin excretion rate and cardiovascular risk: could the association be explained by early microvascular dysfunction? Diabetes 54:1816–1822CrossRefPubMed
19.
go back to reference Alberti KGMM, Zimmet P, Shaw J (2006) Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23:469–480CrossRefPubMed Alberti KGMM, Zimmet P, Shaw J (2006) Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23:469–480CrossRefPubMed
20.
go back to reference Paunescu LA, Schuman JS, Price LL et al (2004) Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using StratusOCT. Invest Ophthalmol Vis Sci 45:1716–1724CrossRefPubMed Paunescu LA, Schuman JS, Price LL et al (2004) Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using StratusOCT. Invest Ophthalmol Vis Sci 45:1716–1724CrossRefPubMed
21.
go back to reference Shore AC, Sandeman DD, Tooke JE (1995) Capillary pressure, pulse pressure amplitude, and pressure waveform in healthy volunteers. Am J Physiol 268:H147–H154PubMed Shore AC, Sandeman DD, Tooke JE (1995) Capillary pressure, pulse pressure amplitude, and pressure waveform in healthy volunteers. Am J Physiol 268:H147–H154PubMed
22.
go back to reference Gamble J, Gartside IB, Christ F (1993) A reassessment of mercury in silastic strain gauge plethysmography for microvascular permeability assessment in man. J Physiol 464:407–422PubMed Gamble J, Gartside IB, Christ F (1993) A reassessment of mercury in silastic strain gauge plethysmography for microvascular permeability assessment in man. J Physiol 464:407–422PubMed
23.
go back to reference Gooding KM, Hannemann MM, Tooke JE, Clough GF, Shore AC (2006) Maximum skin hyperaemia induced by local heating: possible mechanisms. J Vasc Res 43:270–277CrossRefPubMed Gooding KM, Hannemann MM, Tooke JE, Clough GF, Shore AC (2006) Maximum skin hyperaemia induced by local heating: possible mechanisms. J Vasc Res 43:270–277CrossRefPubMed
24.
go back to reference Morris SJ, Shore AC, Tooke JE (1995) Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia 38:1337–1344CrossRefPubMed Morris SJ, Shore AC, Tooke JE (1995) Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia 38:1337–1344CrossRefPubMed
25.
go back to reference Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed
26.
go back to reference Sanchez-Tocino H, Alvarez-Vidal A, Maldonado MJ, Moreno-Montanes J, Garcia-Layana A (2002) Retinal thickness study with optical coherence tomography in patients with diabetes. Invest Ophthalmol Vis Sci 43:1588–1594PubMed Sanchez-Tocino H, Alvarez-Vidal A, Maldonado MJ, Moreno-Montanes J, Garcia-Layana A (2002) Retinal thickness study with optical coherence tomography in patients with diabetes. Invest Ophthalmol Vis Sci 43:1588–1594PubMed
27.
go back to reference Clough GF, Turzyniecka M, Walter L et al (2009) Muscle microvascular dysfunction in central obesity is related to muscle insulin insensitivity but is not reversed by high-dose statin treatment. Diabetes 58:1185–1191CrossRefPubMed Clough GF, Turzyniecka M, Walter L et al (2009) Muscle microvascular dysfunction in central obesity is related to muscle insulin insensitivity but is not reversed by high-dose statin treatment. Diabetes 58:1185–1191CrossRefPubMed
28.
go back to reference Jonk AM, Houben AJ, de Jongh RT, Serne EH, Schaper NC, Stehouwer CD (2007) Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Physiology (Bethesda, MD) 22:252–260 Jonk AM, Houben AJ, de Jongh RT, Serne EH, Schaper NC, Stehouwer CD (2007) Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Physiology (Bethesda, MD) 22:252–260
29.
go back to reference Chan A, Duker JS, Ko TH, Fujimoto JG, Schuman JS (2006) Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography. Arch Ophthalmol 124:193–198CrossRefPubMed Chan A, Duker JS, Ko TH, Fujimoto JG, Schuman JS (2006) Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography. Arch Ophthalmol 124:193–198CrossRefPubMed
30.
go back to reference Michel CC (1997) Starling: the formulation of his hypothesis of microvascular fluid exchange and its significance after 100 years. Exp Physiol 82:1–30PubMed Michel CC (1997) Starling: the formulation of his hypothesis of microvascular fluid exchange and its significance after 100 years. Exp Physiol 82:1–30PubMed
31.
go back to reference Frank RN, Schulz L, Abe K, Iezzi R (2004) Temporal variation in diabetic macular edema measured by optical coherence tomography. Ophthalmology 111:211–217CrossRefPubMed Frank RN, Schulz L, Abe K, Iezzi R (2004) Temporal variation in diabetic macular edema measured by optical coherence tomography. Ophthalmology 111:211–217CrossRefPubMed
32.
go back to reference Larsen M, Wang M, Sander B (2005) Overnight thickness variation in diabetic macular edema. Invest Ophthalmol Vis Sci 46:2313–2316CrossRefPubMed Larsen M, Wang M, Sander B (2005) Overnight thickness variation in diabetic macular edema. Invest Ophthalmol Vis Sci 46:2313–2316CrossRefPubMed
33.
go back to reference Polito A, Del Borrello M, Polini G, Furlan F, Isola M, Bandello F (2006) Diurnal variation in clinically significant diabetic macular edema measured by the Stratus OCT. Retina 26:14–20CrossRefPubMed Polito A, Del Borrello M, Polini G, Furlan F, Isola M, Bandello F (2006) Diurnal variation in clinically significant diabetic macular edema measured by the Stratus OCT. Retina 26:14–20CrossRefPubMed
34.
go back to reference Shore AC, Sandeman DD, Tooke JE (1993) Effect of an increase in systemic blood pressure on nailfold capillary pressure in humans. Am J Physiol 265:H820–H823PubMed Shore AC, Sandeman DD, Tooke JE (1993) Effect of an increase in systemic blood pressure on nailfold capillary pressure in humans. Am J Physiol 265:H820–H823PubMed
35.
go back to reference Frederiksen CA, Jeppesen P, Knudsen ST, Poulsen PL, Mogensen CE, Bek T (2006) The blood pressure-induced diameter response of retinal arterioles decreases with increasing diabetic maculopathy. Graefes Arch Clin Exp Ophthalmol 244:1255–1261CrossRefPubMed Frederiksen CA, Jeppesen P, Knudsen ST, Poulsen PL, Mogensen CE, Bek T (2006) The blood pressure-induced diameter response of retinal arterioles decreases with increasing diabetic maculopathy. Graefes Arch Clin Exp Ophthalmol 244:1255–1261CrossRefPubMed
36.
go back to reference Bruce-Keller AJ, Keller JN, Morrison CD (2009) Obesity and vulnerability of the CNS. Biochim Biophys Acta 1792:395–400PubMed Bruce-Keller AJ, Keller JN, Morrison CD (2009) Obesity and vulnerability of the CNS. Biochim Biophys Acta 1792:395–400PubMed
37.
go back to reference Gugleta K, Mehling M, Kochkorov A et al (2008) Pattern of macular thickness changes measured by ocular coherence tomography in patients with multiple sclerosis. Klin Monatsbl Augenheilkd 225:408–412CrossRefPubMed Gugleta K, Mehling M, Kochkorov A et al (2008) Pattern of macular thickness changes measured by ocular coherence tomography in patients with multiple sclerosis. Klin Monatsbl Augenheilkd 225:408–412CrossRefPubMed
38.
go back to reference Asefzadeh B, Fisch BM, Parenteau CE, Cavallerano AA (2008) Macular thickness and systemic markers for diabetes in individuals with no or mild diabetic retinopathy. Clin Exp Ophthalmol 36:455–463CrossRef Asefzadeh B, Fisch BM, Parenteau CE, Cavallerano AA (2008) Macular thickness and systemic markers for diabetes in individuals with no or mild diabetic retinopathy. Clin Exp Ophthalmol 36:455–463CrossRef
Metadata
Title
Capillary pressure may predict preclinical changes in the eye
Authors
K. M. Gooding
J. E. Tooke
H. von Lany
M. Mitra
R. Ling
C. I. Ball
D. Mawson
K. Skinner
A. C. Shore
Publication date
01-09-2010
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 9/2010
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-010-1805-x

Other articles of this Issue 9/2010

Diabetologia 9/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.